Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. LLY
2. DAVA
3. MONC:IM
4. MONRY
5. NYXH
6. PNR
7. ONON
8. IAUX
9. KKR
10. VICR

Go back to Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
Pfizer Inc. (NYSE: PFE) Delayed: 27.74 --0 (-0%)
Previous Close $27.74    52 Week High $37.39 
Open $27.74    52 Week Low $28.25 
Day High $27.74    P/E 16.81 
Day Low $27.74    EPS $1.65 
Volume 28,864